BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Inflammatory disorder
,
Lung
,
Holistic medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
plasminogen activator inhibitor- 1
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Analysis of 4T1 tumors expressing mouse urokinase plasminogen activitor
Extravillous cytotrophoblasts treated with rosiglitazone
Glomeruli from diabetic OVE26 mice and non-diabetic FVB mice
Hearts and kidneys from PAI-1/SERPINE1 knockout mice
Explore Curated Studies Results
Literature
Most Relevant Literature
Association of the metabolic syndrome with PAI 1act and clot lysis time over a 10-year follow up in …
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Th…
Cardiomyocyte PAI-1 influences the cardiac transcriptome and limits the extent of cardiac fibrosis i…
PAI-1 Regulation of p53 Expression and Senescence in Type II Alveolar Epithelial Cells.
Arid5a/IL-6/PAI-1 Signaling Is Involved in the Pathogenesis of Lipopolysaccharide-Induced Kidney Inj…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Diurnal Variation of Plasminogen Activator Inhibitor-1
4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulat…
Tissue Plasminogen Activator & Plasminogen Activator Inhibitor Type-1 In Gingival Tissues Of Chronic…
Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19
Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ